Boston Scientific cut its full-year outlook after two of its core heart-disease products faced unexpected challenges in the second quarter. Original Image Link Source:www.msn.com
Challenges in the electrophysiology and Watchman businesses led the medtech company to cut its sales and earnings per share forecasts for the second quarter in a row. Original Image Link Source:finance.yahoo.com
Boston Scientific (BSX) lowered its full-year guidance below Wall Street's estimates on Wednesday, citing factors including weak demand for its Watchman heart implant. The medical device maker now ... Original Image Link Source:finance.yahoo.com
By Siddhi Mahatole July 29 (Reuters) - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, citing slower growth for its Watchman heart device and tougher competition in ... Original Image Link Source:www.msn.com
Boston Scientific (BSX) reported Q2 adjusted earnings Wednesday of $0.86 per share, up from $0.75 a year earlier. Analysts polled by FactSet expected $0.83. Net sales for the quar ... Original Image Link Source:finance.yahoo.com
Related Bing News Results Your brain can keep improving into your 90s, study finds Fri, 12 Jun 2026 17:01:00 GMT A three-year study of nearly 4,000 adults ranging from age 19 to 94 found that brain health can improve at any age, challenging the common belief that mental sharpness must decline as we get older. 95% of people carry this virus and scientists may have just found how to stop it Wed, 15 Apr 2026 00:29:00 GMT Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer and chronic disease. By using mice engineered with human antibody genes, ...